Chargement en cours...
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
BACKGROUND: Myocardial ischemia-reperfusion injury (IRI) has become one of the most serious complications after reperfusion therapy in patients with acute myocardial infarction. Small ubiquitin-like modification (SUMOylation) is a reversible process, including SUMO E1-, E2-, and E3-mediated SUMOylat...
Enregistré dans:
| Publié dans: | BMC Cell Biol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6233564/ https://ncbi.nlm.nih.gov/pubmed/30419807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12860-018-0176-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|